1.75 times. (as at 31 December 2019 is 1.90 times). Operating result The consolidated net profit of the Company and its subsidiary for the period 3-month ended 31 March 2020 was Baht 34.60 million

treatments which was generated by the Company. Net Profits There was net loss in the 1st quarter of Year 2019 in amount of Baht 6.27 million, while there was net profit in the 1st quarter of Year 2020 in

31 December 2019 to ending on 31 December 2021 must have a net profit (excluding special items) amounting not less than 100,000,000 per year (the “Second Share Purchase Condition”). The payment for and

before the date of the shareholders' meeting, 30 April 2020 3) Earnings Dilution Because the company has a net loss Therefore cannot calculate the reduction of the profit sharing Adjustment of warrants

asset of the Company is negative. 2. Net Operating Profits Criteria Cannot be calculated since the net profit of the Company is negative. 3. Total Value of Consideration Criteria Total value of

1,465.3 1,202.7 1,007.9 262.6 21.8% 457.4 45.4% Profit for the period 123.4 105.3 102.0 18.1 17.2% 21.4 20.1% In Q3-2017, the Company's total revenue increased from Q2-2017 and Q3-2016, representing an

the Compan al statement r of 2016 a e of net p ed account s net profit ar. This rep 7. Thus, the Q bts of ivable ed 017 ited cussion and nge of Thai ces PCL. ( statements r ending 30 esults can b ny and

) Resolved propose to the Annual Ordinary General Meeting of Shareholders to consider and approve the Balance Sheet and Profit and Loss Statement of the Company for the fiscal year ended December 31, 2017

1,628.5 1,123.0 928.3 505.5 45.0 700.2 75.4 Profit for the period 69.8 102.8 72.1 (33.0) (32.1) (2.3) (3.2) In Q2–2019, the company’s total revenue increased from Q1–2019 and Q2–2018, representing an

, with 0.18 million baht decrease with no significantly transaction changes. 2. Cost of sale , Profit margin For Quarter 1 of the year 2020, the company had cost of sale of 98.36 million bath compare to